ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: PP15

Coordination of Care by a Healthcare Team for Unexpected and Unusual Side Effects Occurring During a Global Pandemic

Laura Genoves, Arthritis Foundation, Bainbridge Island, WA

Meeting: ACR Convergence 2022

Keywords: Access to care, Dermatology, Outcome measures, quality of care, rheumatoid arthritis

  • Tweet
  • Email
  • Print
Session Information

Date: Saturday, November 12, 2022

Title: Patient Perspectives Poster

Session Type: Poster Session A

Session Time: 1:00PM-3:00PM

Background/Purpose: I am a patient who lives with moderate to severe RA. My quality of life is dependent on medications such as a biologic, DMARDs and anti-inflammatories. I live a combined 20-minute drive and 35-minute ferry ride from my healthcare clinic in downtown Seattle, so an in-person visit is not always possible, especially during a pandemic.

Intervention: The specific intervention was coordination of care through multiple channels such as patient portal, telehealth, and in person visits. In June of 2020 I developed an itchy rash. My healthcare is coordinated in Seattle by a multi-specialty clinic. This team includes my primary care physician, rheumatologist, and expanded to include an allergist, dermatologist, dietitian and pathologist. Dermatology took a biopsy, that came back as a lichenoid drug reaction. The issue was, given my cocktail of drugs, which particular drug was the culprit?

Maintenance: The dermatologist was not familiar with RA. She hypothesized that the drug reaction could be caused by several of the mediations I take. My healthcare team started the process of drug elimination and substitution. My dermatologist coordinated with my rheumatologist, and my primary care doctor. I was put on a dose of steroids and over the counter antihistamines. The care team then began the difficult process of communicating among themselves to strategize and plan for a methodical discontinuation of my RA drugs one at a time without causing a flare. I treated the rash with anti-itch steroid creams, oral steroids and antihistamines. After several medication substitutions, my skin condition subsided. My medication regimen changed.

Quality of Life: The notion that a patient can communicate with multiple providers through an online portal, upload photos of a condition when a physical exam is not possible and explain outcomes with these providers through the portal improved my outcome in a situation where care coordination could have been challenging and difficult; trying to explain lab results, discuss likely triggers of a lichenoid drug reaction, and spend valuable clinical time catching up a specific specialist-physician on the latest treatment or test result and overarching plan for treatment. Using a multi-pronged approach with different specialists with different methods of delivering care resulted in an overall positive outcome. Test results, prescriptions and provider notes were all stored in my electronic health record and any treating physician could read through the treatment plan and test results without the barriers involved when utilizing multiple practices. Healthcare systems need to understand patients have a need and ability to communicate with their treating physician in different ways to provide optimum access to care and improve outcomes. The patient experience is far more positive when a healthcare team has the ability to communicate and coordinate seamlessly with each other about a patient. Relying on a patient to understand test results and relay other specialists’ notes to another treating physician can be problematic.

Supporting image 1

Traveling for Access to Healthcare Can Be Problematic

Supporting image 2

During the Pandemic Ferry Service was Limited

Supporting image 3

Patient Supported by the Arthritis Foundation


Disclosures: L. Genoves, None.

To cite this abstract in AMA style:

Genoves L. Coordination of Care by a Healthcare Team for Unexpected and Unusual Side Effects Occurring During a Global Pandemic [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/coordination-of-care-by-a-healthcare-team-for-unexpected-and-unusual-side-effects-occurring-during-a-global-pandemic/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/coordination-of-care-by-a-healthcare-team-for-unexpected-and-unusual-side-effects-occurring-during-a-global-pandemic/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology